Johnson & Johnson withdrawing surgical tool that can spread cancer in women

On Wednesday, July 30th, Johnson & Johnson announced it was withdrawing a surgical tool that can spread cancer in women.  This voluntary recall removed the devices made by the largest manufacturer of those devices from the market amid a contentious debate over its use.

The company planned to tell customers world-wide in a letter to return the devices known as laparoscopic power morcellators. J&J already suspended sales of new morcellators in April after the U.S. Food and Drug Administration advised doctors not to use the tool, which slices up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery. In April, J&J defended the safety of the tool but said it was waiting for more guidance from the medical community.

J&J’s Ethicon unit, the largest maker of the devices, is withdrawing them from the market because the risks and benefits for women undergoing hysterectomies or surgery to remove fibroids remain uncertain, Matthew Johnson, a company spokesman, said yesterday in an e-mail. The decision was reinforced by an FDA meeting earlier this month that highlighted the difficulty in diagnosing cancer before a procedure is performed and the risk of disseminating tumors, he said.

“Due to this continued uncertainty, Ethicon believes that a market withdrawal of Ethicon morcellation devices is the appropriate course of action at this time until further medical guidelines are established and/or new technologies are developed to mitigate the risk,” Johnson said.

Uterine cancers called sarcomas can masquerade as benign fibroids and can’t be reliably detected before surgery. Using a morcellator can inadvertently spread malignancies and other diseased tissues inside the body, possible worsening outcomes. The FDA found that 1 in 350 women who undergo surgery with the devices may have a type of cancer that the procedure can spread beyond the uterus. The seeding of malignant cells in the abdomen and pelvis can significantly worsen a woman’s chance of survival, the agency said.  Last month, a study done by Columbia University researchers underscored the risk.

The problems associated with the morcellator go well beyond typical surgical complications. If you were diagnosed with cancer after uterine surgery, a power morcellator may be to blame. You need to speak with an attorney experienced with medical device cases about your options. If you or a loved one has suffered complications as a result of the use of a power morcellator during surgery for uterine fibroids, please contact the attorneys at the Locks Law Firm.

Tell Us About Your Case

If you can read this, please avoid filling the following input field or your submission may be marked as spam.
Thank you for contacting us! We will be in touch with you shortly.

Recent Entries


Locks Law Firm only provides legal advice after having entered into an attorney client relationship, which our website specifically does not create. Conversations that originate from website messaging, chat or other two way web based engagement  do not create an attorney client relationship. It is imperative that any action taken be done on the advice of counsel. Because every case is different, the description of awards and cases previously handled do not guarantee a similar outcome in current or future cases. The firm practices law in Pennsylvania, New Jersey & New York as Locks Law Firm. Super Lawyers, Best Lawyers in America and other organizations that rate attorneys are not designations that have been approved by the State Supreme Courts or the American Bar Association.